Halogen Containing Patents (Class 570/101)
  • Patent number: 10154596
    Abstract: A catalyst for a catalytic ink includes a support particle and a metallic material supported on the support particle. The metallic material is diamminesilver hydroxide, a silver salt, a palladium salt, a gold salt, chloroauric acid, or combinations thereof. A catalytic ink obtained from the catalyst and use of the same to fabricate a conductive circuit are also disclosed.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: December 11, 2018
    Assignee: TAIWAN GREEN POINT ENTERPRISES CO., LTD.
    Inventors: Pen-Yi Liao, Hui-Ching Chuang, Wen-Chia Tsai, Jing-Yi Yang
  • Patent number: 9896400
    Abstract: Disclosed is a process for producing a chlorinated C3-6 alkane comprising providing a reaction mixture comprising an alkene and carbon tetrachloride in a principal alkylation zone to produce chlorinated C3-6 alkane in the reaction mixture, and extracting a portion of the reaction mixture from the principal alkylation zone, wherein: a) the concentration of the chlorinated C3-6 alkane in the reaction mixture in the principal alkylation zone is maintained at a level such that the molar ratio of chlorinated C3-6 alkane:carbon tetrachloride in the reaction mixture extracted from the alkylation zone does not exceed 95:5 when the principal alkylation zone is in continuous operation; and/or b) the reaction mixture extracted from the principal alkylation zone additionally comprises alkene and the reaction mixture is subjected to a dealkenation step in which at least about 50% or more by weight of the alkene present in the reaction mixture is extracted therefrom and at least about 50% of the extracted alkene is fed ba
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: February 20, 2018
    Assignee: SPOLEK PRO CHEMICKOU A HUTNI VYROBU A.S.
    Inventors: Karel Filas, Pavel Kubicek, Zdenek Ondrus, Petr Sladek
  • Patent number: 9334205
    Abstract: Processes for the production of chlorinated propanes and propenes are provided. The present processes comprise catalyzing at least one chlorination step with one or more regios elective catalysts that provide a regioselectivity to one chloropropane of at least 5:1 relative to other chloropropanes.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: May 10, 2016
    Assignee: Blue Cube IP LLC
    Inventors: Max Markus Tirtowidjojo, Matthew Lee Grandbois, William J. Kruper, Edward M. Calverley, David Stephen Laitar, Kurt Frederick Hirksekorn
  • Patent number: 8946492
    Abstract: A substituted alkenylbenzene compound of formula (4): wherein X1 is selected from the group consisting of a halogen atom, —SF5, C1-C6haloalkyl, hydroxy C1-C6haloalkyl, C1-C6alkoxy C1-C6haloalkyl, C3-C8halocycloalkyl, C1-C6haloalkoxy, C1-C3haloalkoxy C1-C3haloalkoxy, C1-C6haloalkylthio, C1-C6haloalkylsulfinyl and C1-C6haloalkylsulfonyl; X3 is selected from the group consisting of a hydrogen atom, halogen atom, cyano, nitro, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy and C1-C6alkylthio; X4 is selected from the group consisting of a hydrogen atom, halogen atom, cyano, C1-C4alkyl, C1-C4alkoxy and C1-C4haloalkoxy; R3 is —C(R3a)(R3b)R3c, where R3a and R3b independently of each other are a halogen atom, or R3a and R3b together form 3- to 6-membered ring together with the carbon atom bonding them by forming a C2-C5haloalkylene chain, and R3c is selected from the group consisting of a hydrogen atom, halogen atom, C1-C5alkyl, C1-C5haloalkyl, C1-C4haloalkoxy and C1-C4haloalkylthio, with a proviso that in case where X1
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: February 3, 2015
    Assignee: Nissan Chemical Industries, Ltd.
    Inventors: Takeshi Mita, Takamasa Kikuchi, Takashi Mizukoshi, Manabu Yaosaka, Mitsuaki Komoda
  • Patent number: 8936757
    Abstract: Apparatuses and processes are provided for stripping gaseous hydrocarbons from particulate material. One process comprises the step of contacting particles containing hydrocarbons with a stripping vapor in countercurrent flow to remove at least a portion of the hydrocarbons with the stripping vapor to form stripped particles. Contacting the particles includes advancing the particles down a sloping element of a structured packing toward a reinforcing rod that is disposed along a lower channel portion of the sloping element. The particles are advanced over the reinforcing rod. The particles are contacted with the stripping vapor that is rising up adjacent to the lower channel portion.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: January 20, 2015
    Assignee: UOP LLC
    Inventors: Erick D. Gamas-Castellanos, Mitchell John Kowalczyk
  • Patent number: 8921620
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: December 30, 2014
    Assignee: Promega Corporation
    Inventors: Keith V. Wood, Dieter Klaubert, Georgyi V. Los, Robert F. Bulleit, Mark McDougall, Chad Zimprich
  • Publication number: 20140371494
    Abstract: Processes for the production of chlorinated propanes and propenes are provided. The present processes comprise catalyzing at least one chlorination step with one or more regios elective catalysts that provide a regioselectivity to one chloropropane of at least 5:1 relative to other chloropropanes.
    Type: Application
    Filed: December 12, 2012
    Publication date: December 18, 2014
    Inventors: Max Markus Tirtowidjojo, Matthew Lee Grandbois, William J. Kruper, JR., Edward M. Calverley, David Stephen Laitar, Kurt Frederick Hirksekorn
  • Patent number: 8895787
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: November 25, 2014
    Assignee: Promega Corporation
    Inventors: Keith V. Wood, Georgyi V. Los, Robert F. Bulleit, Dieter Klaubert, Mark McDougall, Chad Zimprich
  • Patent number: 8809451
    Abstract: According to the present invention, a polymer is obtained by polycondensation of a fluorinated dicarboxylic acid derivative of the general formula (M-1) or an acid anhydride of the fluorinated dicarboxylic acid with a polyfunctional compound having two to four reactive groups corresponding in reactivity to carbonyl moieties of the fluorinated dicarboxylic acid derivative or acid anhydride. [Chem. 134] AOCF2C-Q-CF2COA???(M-1) In the above formula, Q represents a divalent organic group having a substituted or unsubstituted aromatic ring; and A and A? each independently represent an organic group. This polymer exhibits a sufficiently low dielectric constant for use as a semiconductor protection film and has the capability of forming a film at a relatively low temperature of 250° C. or lower.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: August 19, 2014
    Assignee: Central Glass Company, Limited
    Inventors: Yoshimi Isono, Satoru Narizuka, Hidehisa Nanai, Kazuhiro Yamanaka
  • Patent number: 8801966
    Abstract: Provided are liquid crystal compounds and mixtures incorporating the same. The liquid crystal compounds of the invention generally comprise a cyclopentane group and at least two other rings. In one embodiment, the liquid crystal compounds of the invention comprise a cyclopentane group and at least two other rings, one of which is a fused ring system.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: August 12, 2014
    Assignee: VVI Bright China Ltd.
    Inventors: Xinhua Chen, R. Amaranatha Reddy
  • Patent number: 8778223
    Abstract: Provided are compounds useful for use in liquid crystal mixtures to improve the properties of the mixture. In embodiments, the compound has two cyclohexyl ring and a tail containing one more fluorine atoms.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: July 15, 2014
    Assignee: LC Vision, LLC
    Inventor: Michael Wand
  • Patent number: 8765011
    Abstract: To provide a liquid crystal compound having general physical properties required for the compound, namely, a high stability to heat, light and so forth, a small viscosity, a refractive index anisotropy value having a suitable magnitude, a dielectric constant anisotropy value having a suitable magnitude and steep electro-optical characteristics, a wide temperature range of a nematic phase, and an excellent compatibility with other liquid crystal compounds, in particular, a liquid crystal compound having a wide temperature range of the nematic phase; the compound is represented by formula (1): wherein R is alkenyl having 2 to 20 carbons; ring A1 and ring A2 are independently 1,4-cyclohexylene, or 1,4-phenylene in which at least one of hydrogen may be replaced by fluorine; Z1 and Z2 are independently a single bond, —CH2CH2—, —CH?CH—, —CH2O— or —OCH2—; and n is 0 or 1.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: July 1, 2014
    Assignees: JNC Corporation, JNC Petrochemical Corporation
    Inventors: Teizi Satou, Yasuyuki Goto
  • Patent number: 8742086
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: June 3, 2014
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance P. Encell, Dieter Klaubert, Georgyi V. Los, Mark McDougall, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 8691069
    Abstract: The present disclosure is a system and method for producing a first product from a first region of an electrochemical cell having a cathode and a second product from a second region of the electrochemical cell having an anode. The method may include a step of contacting the first region with a catholyte including carbon dioxide and contacting the second region with an anolyte including a recycled reactant. The method may further include applying an electrical potential between the anode and the cathode sufficient to produce carbon monoxide recoverable from the first region and a halogen recoverable from the second region.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: April 8, 2014
    Assignee: Liquid Light, Inc.
    Inventors: Kyle Teamey, Jerry J. Kaczur, Robert Page Shirtum
  • Publication number: 20140005349
    Abstract: The present invention generally relates to alcohol-terminated polyisobutylene (PIB) compounds, and to a process for making such compounds. In one embodiment, the present invention relates to primary alcohol-terminated polyisobutylene compounds, and to a process for making such compounds. In still another embodiment, the present invention relates to polyisobutylene compounds that can be used to synthesize polyurethanes, to polyurethane compounds made via the use of such polyisobutylene compounds, and to processes for making such compounds. In yet another embodiment, the present invention relates to primary alcohol-terminated polyisobutylene compounds having two or more primary alcohol termini and to a process for making such compounds. In yet another embodiment, the present invention relates to primary terminated polyisobutylene compounds having two or more primary termini selected from amine groups or methacrylate groups.
    Type: Application
    Filed: September 4, 2013
    Publication date: January 2, 2014
    Applicant: The University of Akron
    Inventors: Joseph P. Kennedy, Yongmoon Kwon, Subramanyam Ummadisetty
  • Patent number: 8558041
    Abstract: The present invention provides isothermal multitube reactors suitable for the production of chlorinated and/or fluorinated propene and higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes. The reactors utilize a feed mixture inlet temperature at least 20° C. different from a desired reaction temperature.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: October 15, 2013
    Assignee: Dow Global Technologies, LLC
    Inventors: Max M. Tirtowidjojo, Hua Bai, Debashis Chakraborty, Juergen Eiffler, Heinz Groenewald, Kurt F. Hirsekorn, Manfred Kokott, William J. Kruper, Jr., Thomas U. Luebbe, Avani M. Patel, Shirley S. Sexton, Peter Wenzel, Marcus Wobser
  • Patent number: 8470199
    Abstract: The invention provides a liquid crystal compound having a high stability to heat, light or the like, a nematic phase in a wide temperature range, a small viscosity, a suitable optical anisotropy (especially, a relatively small optical anisotropy), a large elastic constant K33 and a suitable dielectric anisotropy (especially, a relatively large dielectric anisotropy), which is represented by formula (1-1). For example, R1 and R2 are alkyl having 1 to 10 carbons, alkenyl having 2 to 10 carbons or alkoxy having 1 to 9 carbons; the ring A1 and the ring A2 is 1,4-phenylene, 2-fluoro-1,4-phenylene, 3-fluoro-1,4-phenylene or 3,5-difluoro-1,4-phenylene; and m and n are 0, 1, 2 or 3, and the sum of m and n is 3.
    Type: Grant
    Filed: June 2, 2010
    Date of Patent: June 25, 2013
    Assignees: JNC Corporation, JNC Petrochemical Corporation
    Inventor: Masahide Kobayashi
  • Patent number: 8466269
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: June 18, 2013
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance Encell, Dieter Klaubert, Georgyi V. Los, Mark McDougall, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 8410040
    Abstract: An azeotrope-like composition consisting essentially of 1,1,1,2,3-pentachloropropane and hydrogen fluoride is provided, as well as methods that involve such an azeotrope-like composition.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: April 2, 2013
    Assignee: Honeywell International Inc.
    Inventors: Hsueh S. Tung, Hang T. Pham, Rajiv R. Singh, Daniel C. Merkel
  • Patent number: 8378061
    Abstract: Provided are films made from copolyesters having improved oil repellency as compared to conventional copolyesters. The copolyesters are derived from certain perfluorinated monomers.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: February 19, 2013
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Neville Everton Drysdale, Surbhi Mahajan, Kenneth Gene Moloy, Fredrik Nederberg, Joel M. Pollino, Joachim C. Ritter
  • Patent number: 8350099
    Abstract: Disclosed are fluorovinyl ether functionalized aromatic diesters and derivatives thereof. The compounds disclosed have utility as functionalized monomers and comonomers in polyesters, polyamides, and the like. It has been found that incorporation of the monomers into polymers provides improved soil resistance to shaped articles produced from the polymers.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: January 8, 2013
    Assignee: E I du Pont de Nemours and Company
    Inventors: Neville Everton Drysdale, Surbhi Mahajan, Kenneth Gene Moloy, Fredrik Nederberg, Joel M. Pollino, Joachim C. Ritter
  • Patent number: 8304513
    Abstract: Disclosed are polyesters, particularly poly(trimethylene terephthalate), comprising fluorovinylether functionalized aromatic repeat units, and methods to make the polyester polymers. The polymers are useful for imparting soil resistance to polyesters, particularly in the form of fibers, fabrics, and carpets.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: November 6, 2012
    Assignee: E I du Pont de Nemours and Company
    Inventors: Neville Everton Drysdale, Surbhi Mahajan, Kenneth Gene Moloy, Fredrik Nederberg, Joel M. Pollino, Joachim C. Ritter
  • Patent number: 8257939
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: September 4, 2012
    Assignee: Promega Corporation
    Inventors: Keith V. Wood, Georgyi V. Los, Robert F. Bulleit, Dieter Klaubert, Mark McDougall, Chad Zimprich
  • Patent number: 8202700
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: June 19, 2012
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance Encell, Tonny Johnson, Dieter Klaubert, Georgyi V. Los, Mark McDougall, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 8197857
    Abstract: A method for the elimination of carbon dioxide from waste gases includes the following steps. First, waste gases, which include carbon dioxide, are provided from a source for waste gases. Next, the waste gases are contacted with an absorbent composition that includes perfluorodecalin solution. The waste gases, especially the carbon dioxide, are then absorbed by the absorbent composition. The absorbent composition thereby absorbs the waste gases to eliminate the carbon dioxide.
    Type: Grant
    Filed: June 6, 2009
    Date of Patent: June 12, 2012
    Inventors: Lawrence V. Dressler, Alexander Chirkov
  • Patent number: 8168405
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: May 1, 2012
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance Encell, Dieter Klaubert, Georgyi V. Los, Mark McDougall, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 8148584
    Abstract: Compositions comprising are provided wherein RF is a fluorine containing moiety comprising (CF3)2CFCH2(CF3)CH—, (CF3)2CFCH2((CF3)2CF)CH—, (CF3)2CFCH2((CF3)2CH)CH—, (CF3)2CHCH2((CF3)2CF)CH—, ((CF3)2CFCH2)2CH—, (CF3)2CFCH2CF—, (CF3)2CF—, (CF3)2CH—, CF3—, or CnF2n+1—, n being an integer from 2 to 20; R1 is F or H; R2 comprises (CF3)2CF—, (CF3)2CH—, CF3—, F, or H; and R3 comprises (CF3)2CF—, (CF3)2CH—, CF3—, F, or H, such compositions can produced according to processes, and utilized to prevent combustion utilizing systems.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: April 3, 2012
    Assignees: E.I. du Pont de Nemours and Company
    Inventors: Vicki Hedrick, John Chien, Janet Boggs, Andrew Jackson, E. Bradley Edwards, Stephan Brandstadter
  • Publication number: 20110306796
    Abstract: The present invention relates to an improved process for the preparation of 1-bromo-3,5-dimethyl adamantane of formula (III), which is an useful intermediate for synthesis of 1-amino-3,5-dimethyl adamantane of formula (I) or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 30, 2009
    Publication date: December 15, 2011
    Applicant: ALEMBIC LIMITED
    Inventors: Ravi Ponnaiah, Ashok Prasad, Piyush Maheshbhai Rana, Kamlesh Shankarlal Kanzariya, Mitulkumar Bharatkumar Dolia
  • Publication number: 20110306088
    Abstract: A honeycomb body is disclosed having cells extending along a common direction, a first plurality of the cells being open at both ends of the body and a second plurality of the cells being closed at one or both ends of the body, the second plurality of cells arranged in one or more groups of cells cooperating to define one or more fluid passages extending through the body at least in part perpendicularly to the common direction, wherein, in a plane perpendicular to the common direction, the ratio of the area of cells of the first plurality to the area of cells of the second plurality varies along the length of at least one of the one or more fluid passages.
    Type: Application
    Filed: February 26, 2010
    Publication date: December 15, 2011
    Inventors: Peng Chen, Yi Jiang, James Scott Sutherland, Andrew David Woodfin
  • Patent number: 8053616
    Abstract: A method comprising providing a halogen stream; providing a first alkane stream; reacting at least a portion of the halogen stream with at least a portion of the first alkane stream to form a halogenated stream, wherein the halogenated stream comprises alkyl monohalides, alkyl polyhalides, and a hydrogen halide; providing a second alkane stream; and reacting at least a portion of the second alkane stream with at least a portion of the alkyl polyhalides to create at least some additional alkyl monohalides.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: November 8, 2011
    Assignee: GRT, Inc.
    Inventors: Sagar B. Gadewar, Michael D. Wyrsta, Philip Grosso, Aihua Zhang, Eric W. McFarland, Zachary J. A. Komon, Jeffrey H. Sherman
  • Publication number: 20110269989
    Abstract: A method for halogenating, sulfonating, or sulfo-halogenating a feed comprising paraffin, by subjecting a mixture comprising the feed and a reagent selected from the group consisting of sulfonating agents, halogenating agents, and combinations thereof to a shear rate of at least 20,000 s?1 to produce a high-shear treated product; cooling the high shear-treated product by heat exchange with a heat transfer medium, to produce a cooled product; and separating the high shear-treated product into an offgas and a liquid product comprising at least one selected from the group consisting of sulfonated paraffins, halogenated paraffins, and sulfo-halogenated paraffins. A high shear system for the production of halogenated, sulfonated, or sulfo-halogenated paraffin is also provided.
    Type: Application
    Filed: March 2, 2011
    Publication date: November 3, 2011
    Applicant: H R D Corporation
    Inventors: Abbas HASSAN, Krishnan Viswanathan, Rayford G. Anthony, Gregory Borsinger, Aziz Hassan
  • Patent number: 8049042
    Abstract: To provide a resist polymer comprising, as a structural unit, an acid-decomposable unit having a structure represented by formula (1) or (2) which exhibits a small line edge roughness and produces little defects in DUV excimer laser lithography or the like.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: November 1, 2011
    Assignee: Mitsubishi Rayon Co., Ltd.
    Inventors: Hikaru Momose, Atsushi Ootake, Tadashi Nakamura, Akifumi Ueda
  • Patent number: 8044243
    Abstract: Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. Formula (I) wherein n is 1 or 2; q is 0 or 1; t is 0 or 1; R1 is alkyl having from 1 to 3 carbon atoms; R2 is hydrogen, halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3 carbon atoms; A is unsubstituted or substituted phenyl; or cycloalkyl; or a 5 or 6 membered heteroaromatic ring. Alternatively, the agent can be a pharmaceutically acceptable salt of the compound of Formula I.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: October 25, 2011
    Assignee: Wellstat Therapeutics Corporation
    Inventors: Shalini Sharma, Reid W. von Borstel
  • Publication number: 20110237842
    Abstract: An ultraviolet (UV) reactor for carrying out chemical reactions in a pumpable medium by means of UV. The pumpable medium may also be, where appropriate, a multi-phase medium. The UV reactor has a reactor chamber through which the medium can flow In a direction of flow from an inlet to an outlet. The reactor chamber is penetrated by a number of UV transparent jacket tubes, which are arranged one behind the other in the direction of flow. UV emitters are arranged within the jacket tubes for emitting UV radiation into the reactor chamber. The jacket tubes are arranged one behind the other and are interlocked against one another at an angle ?in the circumferential direction of the reactor chamber.
    Type: Application
    Filed: June 2, 2009
    Publication date: September 29, 2011
    Applicant: ITT MANUFACTURING ENTERPRISES, INC.
    Inventors: Ernst Martin Billing, Friedhelm Krüger
  • Patent number: 7935803
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: March 10, 2008
    Date of Patent: May 3, 2011
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance Encell, Dieter Klaubert, Georgyi V. Los, Mark McDougall, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 7888086
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: February 15, 2011
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance Encell, Tonny Johnson, Dieter Klaubert, Georgyi V. Los, Mark McDougall, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 7867726
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: January 11, 2011
    Assignee: Promega Corporation
    Inventors: Keith V. Wood, Dieter Klaubert, Georgyi V. Los, Robert F. Bulleit, Mark McDougall, Chad Zimprich
  • Publication number: 20100276674
    Abstract: An organic light-emitting device comprising an anode; a hole transport layer; a light-emitting layer; and a cathode, characterised in that the hole transport layer comprises a polymer having a repeat unit comprising a 9,9 biphenyl fluorene unit wherein the 9-phenyl rings are independently and optionally substituted and the fluorene unit is optionally fused.
    Type: Application
    Filed: November 18, 2008
    Publication date: November 4, 2010
    Applicants: CAMBRIDGE DISPLAY TECHNOLOGY LIMITED, SUMATION CO., LIMITED
    Inventors: Natasha M. Conway, Mary J. McKiernan, Brian Tierney
  • Publication number: 20100152479
    Abstract: A tube bundle falling film microreactor for performing gas-liquid reactions, which has: a) at least one vertical tube with b) a device for distributing the liquid on the inside of the tube and c) a liquid collecting system, and d) a device for gas supply and removal, and use thereof.
    Type: Application
    Filed: May 28, 2008
    Publication date: June 17, 2010
    Inventors: Florian Seebauer, Peter Poechlauer, Sascha Braune, Stefan Steinhofer
  • Publication number: 20100099929
    Abstract: A method comprising: providing a first halogen stream; providing a first alkane stream; reacting at least a portion of the first halogen stream with at least a portion of the first alkane stream in a first reaction vessel to form a first halogenated stream; providing a second alkane stream comprising C2 and higher hydrocarbons; providing a second halogen stream; and reacting at least a portion of the second halogen stream with at least a portion of the second alkane stream in a second reaction vessel to form a second halogenated stream.
    Type: Application
    Filed: July 17, 2009
    Publication date: April 22, 2010
    Inventors: Sagar Gadewar, Michael Wyrsta, Philip Grosso, Aihua Zhang, Eric W. McFarland, Zachary J.A. Komon, Jeffrey H. Sherman, Peter Stoimenov, Hongfei Lin, Shawn Huff, Shouli Sun
  • Publication number: 20100099930
    Abstract: A method comprising: providing an alkyl halide stream; contacting at least some of the alkyl halides with a coupling catalyst to form a product stream comprising higher hydrocarbons and hydrogen halide; contacting the product stream with a solid reactant to remove at least a portion of the hydrogen halide from the product stream; and reacting the solid reactant with a source of oxygen to generate a corresponding halogen.
    Type: Application
    Filed: July 17, 2009
    Publication date: April 22, 2010
    Inventors: Peter Stoimenov, Charles Ian Cutier, Jihong Cheng, Charles J. Coronelia, Krishna Janmanchi, Zachary J.A. Komon, Saydul Amin Sardar, Vivek Julka, Sagar Gadewar, Philip Grosso, Daniel J. Auerbach, Jean Wheeler
  • Publication number: 20100099928
    Abstract: A method comprising providing a halogen stream; providing a first alkane stream; reacting at least a portion of the halogen stream with at least a portion of the first alkane stream to form a halogenated stream, wherein the halogenated stream comprises alkyl monohalides, alkyl polyhalides, and a hydrogen halide; providing a second alkane stream; and reacting at least a portion of the second alkane stream with at least a portion of the alkyl polyhalides to create at least some additional alkyl monohalides.
    Type: Application
    Filed: July 1, 2009
    Publication date: April 22, 2010
    Inventors: Sagar B. Gadewar, Michael D. Wyrsta, Philip Grosso, Aihua Zhang, Eric W. McFarland, Zachary J.A. Komon, Jeffrey H. Sherman
  • Publication number: 20090105260
    Abstract: An IR spectroscopic technique provides methods for measuring the irritation potential of a formulation and to assess the ability of molecules to enhance the permeability of substances into and through skin using samples comprising stratum corneum. Molecules are screened for their performance as chemical penetration enhancers using a unique in silico procedure that may be applied iteratively in an attempt to generate molecules showing successively higher performance. Both the irritation potential and the ability of the molecule to enhance penetration are considered in the in silico approach. The invention provides specific molecules that may be used in topical or transdermal formulations to improve the delivery of actives. The structures of compounds of the invention include: Formulas (I), (II), (III), (IV), (V), (IV) and analogs thereof.
    Type: Application
    Filed: January 17, 2006
    Publication date: April 23, 2009
    Inventors: Samir Mitragotri, Pankaj Karande, Amit K. Jain
  • Patent number: 7482498
    Abstract: The invention relates to a device and a process for nucleophilic fluorination of a substance, especially for synthesis of an 18F-labeled substance for examination using a positron emission tomograph. The device comprises an anion exchange device (102) for extraction of [18F]fluoride ions by means of adsorption from a target fluid, whereby the anion exchange device (102) can be charged via a supply device (101) with the target fluid; and a measurement device (104) with a measurement chamber (103) for measuring initial radioactivity of the [18F]fluoride ions, the anion exchange device (102) being arranged at least partially in the measurement chamber (103) of the measurement device (104).
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: January 27, 2009
    Assignee: Schering AG
    Inventors: Peter Maeding, Frank Fuechtner
  • Patent number: 7465841
    Abstract: A method and a device for purifying 1,4-bis(bromodifluoromethyl)benzene are disclosed. In order to solve the problem of hard to purify and separate 1,4-bis(bromodifluoromethyl)benzene crude products, diphenylmethane that has a higher boiling point and does not interact with 1,4-bis(bromodifluoromethyl)benzene is mixed with the 1,4-bis(bromodifluoromethyl)benzene crude products for evaporation. Afterwards, the purity of the vaporized product is detected and only that reaching an expected purity is collected to obtain high-purity 1,4-bis(bromodifluoromethyl)benzene.
    Type: Grant
    Filed: July 27, 2004
    Date of Patent: December 16, 2008
    Assignee: Chung Shan Institute of Science and Technology
    Inventors: Shean-Jeng Jong, Chun-Hsu Lin, Chao-Chou Tu, Chung-Chien Chang
  • Patent number: 7425436
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate and has at least two amino acid substitutions relative to the wild-type hydrolase. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: September 16, 2008
    Assignee: Promega Corporation
    Inventors: Aldis Darzins, Lance Encell, Georgyi V. Los, Keith V. Wood, Monika G. Wood, Chad Zimprich
  • Patent number: 7262323
    Abstract: A method for producing high purity terephthalic acid wherein a slurry having an acetic acid solvent and, dispersed therein, crude terephthalic acid crystals which has been prepared by subjecting a p-alkyl benzene to a liquid phase oxidation in a solvent of acetic acid is continuously converted to a water slurry by the mother liquid exchange, and then the resultant water slurry is subjected to a hydrogenation treatment, which comprises introducing the above acetic acid slurry to a tower having a center axis having a plurality of agitating blades at the top thereof, to form a region having a high concentration of terephthalic acid crystals in the tower through the sedimentation of the terephthalic acid crystals, supplying the water for substitution to the bottom of the tower in such a manner to form an upward water flow while generating a revolving flow of the high concentration region by the rotation of the agitation blade, to thereby subject said terephthalic acid crystals and said upward water flow to a coun
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: August 28, 2007
    Assignees: Mitsubishi Gas Chemical Company, Inc., Toyo Boseki Kabushiki Kaisha, Mizushima Aroma Company, Ltd.
    Inventors: Hideaki Fujita, Hiroshi Machida, Nobuo Namiki, Yoshio Waguri
  • Patent number: 7238842
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: July 3, 2007
    Assignee: Promega Corporation
    Inventors: Keith V. Wood, Dieter Klaubert, Georgyi V. Los, Robert F. Bulleit, Mark McDougall, Chad Zimprich
  • Patent number: 7223891
    Abstract: The invention relates to a process for the production of an [18F]fluorohaloalkane which comprises treatment of a solid support-bound precursor of formula (I): SOLID SUPPORT-LINKER-SO2—O—(CH2)nX (I) wherein n is an integer of from (1) to (7) and X is chloro, bromo or iodo; with 18F? to produce the [18F]fluorohaloalkane of formula (II) 18F—(CH2)n—X (II) wherein n and X are as defined for the compound of formula (I), optionally followed by (i) removal of excess 18F?, for example by ion-exchange chromatography; and/or (ii) removal of organic solvent.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: May 29, 2007
    Assignee: Hammersmith Imanet Ltd.
    Inventors: Frank Brady, Sajinder Kaur Luthra, Yongjun Zhao
  • Patent number: RE42931
    Abstract: A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: November 15, 2011
    Assignee: Promega Corporation
    Inventors: Keith V. Wood, Dieter Klaubert, Georgyi V. Los, Robert F. Bulleit, Mark McDougall, Chad Zimprich